A cancer therapeutic nanoparticle vaccine targeting HAAH improves 3-week survival from 12.5% to 100% in a mouse model of metastatic breast cancer

Fuller, Steven; Lebowitz, Michael S; Stewart, Solomon; Ghanbari, Hossein A

doi:10.1186/2051-1426-2-S3-P52

Article metrics
Last updated: Thu, 25 Apr 2024 1:00:03 Z

A cancer therapeutic nanoparticle vaccine targeting HAAH improves 3-week survival from 12.5% to 100% in a mouse model of metastatic breast cancer

Access & Citations

764

Article Accesses
0

Web of Science
0

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.